These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7619955)

  • 21. [Mucocutaneous lichen planus induced by a second treatment with high-dose interferon-alpha in a patient with chronic viral hepatitis C].
    Perreard M; Constant T; Monges D; Djaghri N; Angeli-Besson C; Gerolami A
    Gastroenterol Clin Biol; 1994; 18(11):1051. PubMed ID: 7705576
    [No Abstract]   [Full Text] [Related]  

  • 22. Ribavirin/interferon-alpha sequential treatment of recurrent hepatitis C after liver transplantation.
    Giostra E; Kullak-Ublick GA; Keller W; Fried R; Vanlemmens C; Kraehenbuhl S; Locher S; Egger HP; Clavien PA; Hadengue A; Mentha G; Morel P; Negro F
    Transpl Int; 2004 May; 17(4):169-76. PubMed ID: 15060764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin.
    Ahmad J; Dodson SF; Demetris AJ; Fung JJ; Shakil AO
    Liver Transpl; 2001 Oct; 7(10):863-9. PubMed ID: 11679984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon and steroid treatment in patients with chronic hepatitis C and antinuclear or anti-liver-kidney microsomal antibodies.
    Provenzano G; Almasio P; Fabiano C; Magrin S; Pinzello G; Vaccaro A; Craxì A
    Ital J Gastroenterol; 1996 Sep; 28(7):377-80. PubMed ID: 8937938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of viral hepatitis C: what are the perspectives?].
    Giostra E; Malè PJ
    Rev Med Suisse Romande; 1994 Sep; 114(9):759-64. PubMed ID: 7939106
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of daily administration period of natural alpha-interferon in patients with chronic hepatitis C.
    Toyoda H; Nakano S; Kumada T; Takeda I; Sugiyama K; Osada T; Kiriyama S
    Am J Gastroenterol; 1996 Apr; 91(4):743-7. PubMed ID: 8677941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in serum fibrogenesis markers during interferon therapy for chronic hepatitis type C.
    Ishibashi K; Kashiwagi T; Ito A; Tanaka Y; Nagasawa M; Toyama T; Ozaki S; Naito M; Azuma M
    Hepatology; 1996 Jul; 24(1):27-31. PubMed ID: 8707274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interferon-alpha in chronic hepatitis C].
    Swobodnik W
    Dtsch Med Wochenschr; 1995 Aug; 120(34-35):1186. PubMed ID: 7656857
    [No Abstract]   [Full Text] [Related]  

  • 29. Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: a multicenter randomized controlled trial.
    Kasahara A; Hayashi N; Hiramatsu N; Oshita M; Hagiwara H; Katayama K; Kato M; Masuzawa M; Yoshihara H; Kishida Y
    Hepatology; 1995 Feb; 21(2):291-7. PubMed ID: 7843696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [When should the treatment with interferon alpha be discontinued in chronic hepatitis C?].
    Castilla Cortázar A
    Med Clin (Barc); 1993 Dec; 101(20):774-6. PubMed ID: 8114538
    [No Abstract]   [Full Text] [Related]  

  • 31. alpha-Interferon retreatment of patients with chronic hepatitis C.
    Rabinovitz M; Block G; Finkelstein SD
    Am J Gastroenterol; 1996 Aug; 91(8):1523-6. PubMed ID: 8759654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment.
    Bellobuono A; Mondazzi L; Tempini S; Silini E; Idéo G
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1169-77. PubMed ID: 9471022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy in chronic hepatitis C: say goodbye to the 6-month interferon regimen.
    Koff RS
    Am J Gastroenterol; 1996 Oct; 91(10):2072-4. PubMed ID: 8855723
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
    Olaso V; Córdoba J; Berenguer M; Prieto M; Lainez B; Argüello L; Valverde J; Pascual S; Gobernado M; Berenguer J
    Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant interferon-alpha and ursodeoxycholic acid versus interferon-alpha alone in the treatment of chronic hepatitis C: a randomized clinical trial with long-term follow-up.
    Angelico M; Gandin C; Pescarmona E; Rapicetta M; Del Vecchio C; Bini A; Spada E; Baroni CD; Capocaccia L
    Am J Gastroenterol; 1995 Feb; 90(2):263-9. PubMed ID: 7847298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breakthrough during recombinant interferon alfa therapy in patients with chronic hepatitis C virus infection: prevalence, etiology, and management.
    Roffi L; Mels GC; Antonelli G; Bellati G; Panizzuti F; Piperno A; Pozzi M; Ravizza D; Angeli G; Dianzani F
    Hepatology; 1995 Mar; 21(3):645-9. PubMed ID: 7875661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Essential mixed cryoglobulinemia (EMC) in a case of chronic hepatitis C--successful treatment with interferon alpha.
    Pingel S; Hartmann H; Ramadori G
    Z Gastroenterol; 1994 Oct; 32(10):584-8. PubMed ID: 7716994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Predictive factors of response to interferon-alpha treatment in chronic hepatitis C].
    Buti M; Esteban R
    Rev Esp Enferm Dig; 1997 Jul; 89(7):501-2. PubMed ID: 9303619
    [No Abstract]   [Full Text] [Related]  

  • 39. Interferon-alpha therapy for hepatitis C virus recurrence after liver transplantation: long-term response with maintenance therapy.
    Singh N; Gayowski T; Wannstedt CF; Marino IR; Wagener MM
    Clin Transplant; 1996 Aug; 10(4):348-51. PubMed ID: 8884107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Large dose natural interferon alpha therapy for patients with chronic hepatitis C.
    Ohmiya M; Hayashi J; Furusyo N; Ueno K; Kishihara Y; Nabeshima S; Kashiwagi S
    Fukuoka Igaku Zasshi; 1997 Dec; 88(12):380-8. PubMed ID: 9465478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.